ORAL LESIONS IN INFLAMMATORY BOWEL DISEASES

DOI: https://doi.org/10.29296/25877305-2021-10-04
Download full text PDF
Issue: 
10
Year: 
2021

Professor Yu. Uspenskiy(1, 2), MD; Professor Yu. Fominykh(1, 2), MD; A. Gnutov(1)
(1)St.Petersburg State Pediatric Medical University (2)Pavlov First St-Petersburg State Medical University

Crohn’s disease and ulcerative colitis are chronic recurrent inflammatory diseases of the gastrointestinal tract, according to modern concepts, environmental aspects, intestinal microflora, genetic predisposition and impaired immune response to intestinal microbiota play an important role in the pathogenesis of these diseases. In addition to clinical manifestations from the gastrointestinal tract, inflammatory bowel disease can manifest itself with extraintestinal symptoms, among which one of the most common are lesions of the oral cavity. This review examines the specific and nonspecific manifestations of inflammatory bowel diseases in the oral cavity, as well as lesions of the oral cavity that develop as a result of malabsorption syndrome and during drug intake. Oral lesions, which can both precede intestinal manifestations and occur after the manifestation of inflammatory bowel diseases, require special attention from gastroenterologists and dental specialists.
Keywords: 
gastroenterology
Crohn’s disease
ulcerative colitis
oral lesions
aphthous stomatitis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. 1. Uspenskij Ju.P., Ivanov S.V., Majorova O.V. i dr. Vospalitel'nye zabolevanija kishechnika i ozhirenie: sovremennoe sostojanie problemy. Meditsinskij alfavit. 2020; 37: 29–34 [Uspenskiy Yu.P., Ivanov S.V., Mayorova O.V. et al. Inflammatory bowel disease and obesity: current state of issue. Medical alphabet. 2020; 37: 29–34 (in Russ.)]. DOI: 10.33667/2078-5631-2020-37-29-34
  2. 2. Veselov A.V., Belousova E.A., Bakulin I.G. i dr. Otsenka ekonomicheskogo bremeni i tekuschego sostojanija organizatsii lekarstvennogo obespechenija patsientov s immunovospalitel'nymi zabolevanijami (na primere jazvennogo kolita i bolezni Krona) v Rossijskoj Federatsii. Problemy sotsial'noj gigieny, zdravoohranenija i istorii meditsiny. 2020; 28 (spetsvypusk): 1137–45 [Veselov A.V., Belousova E.A., Bakulin I.G. et al. Economic burden and current status of the drug supply management for immune inflammatory diseases (by example of ulcerative colitis and Crohn’s disease). Problemi socialnoi gigieni, zdravookhranenia i istorii meditsini. 2020; 28 (Special Issue): 1137–45 (in Russ.)]. DOI: 10.32687/0869-866X-2020-28-s2-1137-1145
  3. 3. Uspenskij Ju.P., Nadzhafova K.N., Fominyh Ju.A. i dr. Ekstraintestinal'nye porazhenija pri vospalitel'nyh zabolevanijah kishechnika: fokus na gepatobiliarnuju sistemu. Farmateka. 2021; 28 (2): 36–42 [Uspensky Yu.P., Nadzhafova K. N., YU. A. Fominykh et al. Extraterestinal lesions in inflammatory bowel diseases: focus on the hepatobiliary system. Farmateka. 2021; 28 (2): 36–42 (in Russ.)]. DOI: 10.18565/pharmateca.2021.2.36-42
  4. 4. Muhvić-Urek M., Tomac-Stojmenović M., Mijandrušić-Sinčić B. Oral pathology in inflammatory bowel disease. World J Gastroenterol. 2016; 22 (25): 5655–67. DOI: 10.3748/wjg.v22.i25.5655
  5. 5. Tan C.X., Brand H.S., de Boer N.K. et al. Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn’s disease. Br Dent J. 2016; 221 (12): 794–9. DOI: 10.1038/sj.bdj.2016.954. PMID: 27982000
  6. 6. Lauritano D., Boccalari E., Di Stasio D. et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics (Basel). 2019; 9 (3): 77. DOI: 10.3390/diagnostics9030077
  7. 7. Chi A.C., Neville B.W., Krayer J.W. et al. Oral manifestations of systemic disease. Am Fam Physician. 2010; 82 (11): 1381–8.
  8. 8. Jurge S., Hegarty A.M., Hodgson T. Orofacial manifestations of gastrointestinal disorders. Br J Hosp Med (Lond). 2014; 75 (9): 497–501. DOI: 10.12968/hmed.2014.75.9.497
  9. 9. Álvarez-Garrido H., Pericet-Fernández L., Martinez-Garcia G. et al. Crohn’s disease and cheilitis granulomatosa: role of silicone fillers. J Am Acad Dermatol. 2011; 65: 239–41. DOI: 10.1016/j.jaad.2009.12.055
  10. 10. de Castro López M.J., Illade Quinteiro L., Martinón Torres F. et al. Read my lips: oral manifestations of systemic diseases. J Pediatr. 2013; 163 (6): 1784–5. DOI: 10.1016/j.jpeds.2013.06.080
  11. 11. Zhilin S.A., Radchenko V.G., Dobritsa V.P. Vnekishechnye projavlenija vospalitel'nyh zabolevanij kishechnika. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova. 2013; 5 (2): 111–7 [Zhilin S.A., Radchenko V.G., Dobritsa V.P. Extraintestinal manifestations of inflammatory bowel disease. Herald of North-Western state medical university named after I. I. Mechnikov. 2013; 5 (2): 111–7 (in Russ.)].
  12. 12. Al-Hamad A., Porter S., Fedele S. Orofacial Granulomatosis. Dermatol Clin. 2015; 33 (3): 433–46. DOI: 10.1016/j.det.2015.03.008
  13. 13. Robakidze N.S. Sovremennye predstavlenija o patogeneze sochetannyh zabolevanij polosti rta i zheludochno-kishechnogo trakta. Institut stomatologii. 2020; 89: 64–5 [Robakidze, N.S. Modern concepts of the pathogenesis of combined diseases of the oral cavity and gastrointestinal tract. Institut stomatologii. 2020; 89: 64–5 (in Russ.)].
  14. 14. Robakidze N.S., Schukina O.B. Patogeneticheskie aspekty porazhenija polosti rta pri vospalitel'nyh zabolevanijah kishechnika. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2019; 29 (4): 15–21 [Robakidze N.S., Shchukina O.B. Pathogenetic Aspects of Oral Cavity Lesions in Inflammatory Gastrointestinal Tract Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019; 29 (4): 15–21 (in Russ.)]. DOI: 10.22416/1382-4376-2019-29-4-15-21
  15. 15. Kumar K.M., Nachiammai N., Madhushankari G.S. Association of oral manifestations in ulcerative colitis: A pilot study. J Oral Maxillofac Pathol. 2018; 22 (2): 199–203. DOI: 10.4103/jomfp.JOMFP_223_16
  16. 16. Kudishina M.M., Kozlova I.V. Ekstraintestinal'nye projavlenija vospalitel'nyh zabolevanij kishechnika. Effektivnaja farmakoterapija. 2019; 15 (18): 52–8 [Kudishina M.M., Kozlova I.V. Extra-Intestinal Manifestations of Inflammatory Bowel Diseases. Ehffektivnaya farmakoterapiya. 2019; 15 (18): 52–8 (in Russ.)]. DOI: 10.33978/2307-3586-2019-15-18-52-58
  17. 17. Tan C.X., Brand H.S., de Boer N.K. et al. Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis. Br Dent J. 2017; 222 (1): 53–7. DOI: 10.1038/sj.bdj.2017.37
  18. 18. Jurge S., Hegarty A.M., Hodgson T. Orofacial manifestations of gastrointestinal disorders. Br J Hosp Med (Lond). 2014; 75 (9): 497–501. DOI: 10.12968/hmed.2014.75.9.497 19. Robakidze N.S. Analiz techenija retsidivirujuschego aftoznogo stomatita u bol'nyh s vospalitel'nymi zabolevanijami kishechnika. Institut stomatologii. 2016; 1 (70): 58–9 [Robakidze N.S. The analysis of recurrent aphthous stomatitis of the patients with inflammatory bowel disease. Institut stomatologii. 2016; 1 (70): 58–9 (in Russ.)]
  19. 20. Grössner-Schreiber B., Fetter T., Hedderich J. et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006; 33 (7): 478–84. DOI: 10.1111/j.1600-051X.2006.00942.x
  20. 21. Ivanov S.V., Uspenskij Ju.P., Fominyh Ju.A. i dr. Anemija pri jazvennom kolite: nutritsionnye aspekty. Meditsina: teorija i praktika. 2018; 3 (1): 34–5 [Ivanov S.V., Uspensky Yu.P., Fominykh Yu.A. et al. Anemiya pri yazvennom kolite: nutritsionnye aspekty. Meditsina: teoriya i praktika. 2018; 3 (1): 34–5 (in Russ.)].
  21. 22. Yuan A., Woo S.B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 119 (1): 35–47. DOI: 10.1016/j.oooo.2014.09.009
  22. 23. Gorobets S.M., Romanenko I.G., Dzherelej A.A. i dr. Stomatologicheskie aspekty projavlenija nezhelatel'nyh lekarstvennyh reaktsij. Tavricheskij mediko-biologicheskij vestnik. 2018; 21 (3): 166–74 [Gorobets S.M., Romanenko I.G., Dzhereley A.A. et al. Dental aspects of manifestation undesirable medicine reactions. Tavricheskii mediko-biologicheskii vestnik. 2018; 21 (3): 166–74 (in Russ.)]
  23. 24. Dave M., Purohit T., Razonable R. et al. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014; 20 (1): 196–212. DOI: 10.1097/MIB.0b013e3182a827d2
  24. 25. Ellul P., Vella V., Vassallo M. Reversible dysgeusia attributed to azathioprine. Am J Gastroenterol. 2007; 102 (3): 689. DOI: 10.1111/j.1572-0241.2007.01040_6.x
  25. 26. Truhan D.I., Goloshubina V.V., Truhan L.Ju. Izmenenija so storony organov i tkanej polosti rta pri gastroenterologicheskih zabolevanijah. Eksperimental'naja i klinicheskaja gastroenterologija. 2015; 3 (115): 90–3 [Trukhan D.I., Goloshubina V.V., Trukhan L.Yu. Changes in the organs and tissues of the oral cavity with digestive system diseases. Ehksperimental’naya i klinicheskaya gastroehnterologiya. 2015; 3 (115): 90–3 (in Russ.)].
  26. 27. Ribaldone D.G., Brigo S., Mangia M. et al. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines (Basel). 2020; 7 (6): 33. DOI: 10.3390/medicines7060033